Company Announcement no. 4 2009/10 - Annual General Meeting in Ambu A/S on 16 December 2009

The shareholders considered the management’s review, and the Annual Report for 2008/09 was adopted. The management’s review included an outline of the Board of Directors’ intention of offering employees the opportunity to subscribe shares in connection with the end of the financial year as permitted under the authorisation set out in the present Articles of Association and moreover the Board of Directors intends to introduce a new incentive scheme for senior employees, which will run for a number of years.
 

The allocation of employee shares and options will be based on Ambu realising the financial targets defined for the individual years within the framework of the new strategy plan.
The distribution of the profit for the year proposed in the adopted Annual Report for 2008/09 was adopted, and dividend of DKK 1.50 per share will consequently be distributed, corresponding to 32% of the net profit.
 

Members of the Board of Directors Bjørn Ragle and John Stær were reelected. Moreover, elections of employee directors have been held in Ambu. Anne-Marie Jensen and Hanne-Merete Lassen have been reelected, while Anne Blanksø Pedersen is replacing Kirsten Therkildsen Søndersted-Olsen as a new member.

The company auditors PricewaterhouseCoopers Statsautoriseret Revisionsaktieselskab were reappointed. Furthermore, the Board of Directors was authorised to acquire, in the period until next year’s annual general meeting, treasury shares representing up to 10% of the share capital and at the bid price quoted by the OMX Nordic Exchange Copenhagen plus or minus up to 10%.

Two proposals from a shareholder were not adopted.
 

At the following meeting of the Board of Directors, Chairman of the Board N. E. Nielsen and Deputy Chairman of the Board Bjørn Ragle were reelected.
 

Download the Company Announcement in PDF format.

Download the presentation from the General Meeting in PDF format. 

Further information:
 

Lars Marcher, CEO, phone +45 5136 2490, e-mail: lm@ambu.com
 

Ambu develops, produces and markets diagnostic and life-supporting devices for hospitals and rescue services. Ambu has three business areas: Airway Management, Patient Monitoring & Diagnostics and Emergency Care. The primary products are ventilation products for artificial respiration, electrodes for ECG tests and neurophysiological tests, and manikins for first aid training. Ambu’s products are sold worldwide. Exports account for 98% of sales, and sales are handled via Ambu’s foreign subsidiaries or via distributors. Ambu has approximately 1,600 employees, of whom 300 work in Denmark and 1,300 abroad.